A series of previous studies have demonstrated that HIF-1α can exacerbate bladder cancer progression, including promoting EMT process [51] and cell growth [52] and conferring the chemo-resistance to cisplatin of bladder cancer cells [53]. Here, HIF1A is linked to urinary bladder carcinoma.